» Articles » PMID: 21536691

Impact of Neurocognition on Social and Role Functioning in Individuals at Clinical High Risk for Psychosis

Overview
Journal Am J Psychiatry
Specialty Psychiatry
Date 2011 May 4
PMID 21536691
Citations 69
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Cognitive deficits have been well documented in schizophrenia and have been shown to impair quality of life and to compromise everyday functioning. Recent studies of adolescents and young adults at high risk for developing psychosis show that neurocognitive impairments are detectable before the onset of psychotic symptoms. However, it remains unclear how cognitive impairments affect functioning before the onset of psychosis. The authors assessed cognitive impairment in adolescents at clinical high risk for psychosis and examined its impact on social and role functioning.

Method: A sample of 127 treatment-seeking patients at clinical high risk for psychosis and a group of 80 healthy comparison subjects were identified and recruited for research in the Recognition and Prevention Program. At baseline, participants were assessed with a comprehensive neurocognitive battery as well as measures of social and role functioning.

Results: Relative to healthy comparison subjects, clinical high-risk patients showed significant impairments in the domains of processing speed, verbal memory, executive function, working memory, visuospatial processing, motor speed, sustained attention, and language. Clinical high-risk patients also displayed impaired social and role functioning at baseline. Among patients with attenuated positive symptoms, processing speed was related to social and role functioning at baseline.

Conclusions: These findings demonstrate that cognitive and functional impairments are detectable in patients at clinical high risk for psychosis before the onset of psychotic illness and that processing speed appears to be an important cognitive predictor of poor functioning.

Citing Articles

Schizophasia and Cognitive Impairment in Schizophrenia: A Literature Review.

Niedzwiadek S, Szulc A Brain Sci. 2025; 15(1).

PMID: 39851393 PMC: 11763409. DOI: 10.3390/brainsci15010025.


The association of the comorbidity status of metabolic syndrome and cognitive dysfunction with health-related quality of life.

Lin Y, Chang H, Wang Y, Fuh J, Wang S, Chen H Qual Life Res. 2024; 33(12):3421-3433.

PMID: 39269582 DOI: 10.1007/s11136-024-03784-z.


Improving processing speed in adolescents at clinical high risk for psychosis with the Specific COgnitive REmediation plus Surround (SCORES) intervention: Study protocol.

Carrion R, Auther A, McLaughlin D, John M, Cornblatt B Early Interv Psychiatry. 2024; 19(1):e13587.

PMID: 38951112 PMC: 11905519. DOI: 10.1111/eip.13587.


Prevalence, correlates and explanatory models of cognitive deficits in patients with schizophrenia-A cross sectional study.

Uppinkudru C, Gopalakrishnan R, Noel J, Kuruvilla A Indian J Psychiatry. 2023; 65(10):1025-1034.

PMID: 38108049 PMC: 10725214. DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_102_23.


Beyond verbal fluency in the verbal fluency task: semantic clustering as a predictor of remission in individuals at clinical high risk for psychosis.

Choe E, Ha M, Choi S, Park S, Jang M, Kim M J Psychiatry Neurosci. 2023; 48(6):E414-E420.

PMID: 37914223 PMC: 10620004. DOI: 10.1503/jpn.230074.


References
1.
Cannon T, Cadenhead K, Cornblatt B, Woods S, Addington J, Walker E . Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Arch Gen Psychiatry. 2008; 65(1):28-37. PMC: 3065347. DOI: 10.1001/archgenpsychiatry.2007.3. View

2.
Snitz B, MacDonald 3rd A, Carter C . Cognitive deficits in unaffected first-degree relatives of schizophrenia patients: a meta-analytic review of putative endophenotypes. Schizophr Bull. 2005; 32(1):179-94. PMC: 2632195. DOI: 10.1093/schbul/sbi048. View

3.
Bowie C, Reichenberg A, Patterson T, Heaton R, Harvey P . Determinants of real-world functional performance in schizophrenia subjects: correlations with cognition, functional capacity, and symptoms. Am J Psychiatry. 2006; 163(3):418-25. DOI: 10.1176/appi.ajp.163.3.418. View

4.
Green M, Kern R, Braff D, Mintz J . Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr Bull. 2001; 26(1):119-36. DOI: 10.1093/oxfordjournals.schbul.a033430. View

5.
Elvevag B, Goldberg T . Cognitive impairment in schizophrenia is the core of the disorder. Crit Rev Neurobiol. 2001; 14(1):1-21. View